As Glo1 is highly expressed in both melanoma and non-melanoma skin cancer, we proposed that Glo1 is a novel target in skin cancer and more extensive studies are necessary in future animal and clinical studies for future drug development against skin cancer. This evidence concerns the gene GLO1 and melanoma.